IFNAR1 and Zika virus infectious disease: Intradermal electroporation of as few as 1 μg of this mRNA-based ZIKV vaccine induced potent humoral and cellular immune responses in BALB/c and especially IFNAR1-/- C57BL/6 mice, resulting in a complete protection of the latter mice against ZIKV infection.